Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

[Ketua Dobbs]

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
Source: Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function